Home Catalent

Catalent

acquired
IPO Delisting
Integrated Services, Drug Delivery Technology, and Manufacturing Solutions Provider
Basic
Enterprise Profile
LinkedIn

Basic Information

Catalent is a global leader in providing integrated services, advanced drug delivery technologies, and manufacturing solutions to help life science innovators develop and launch successful pharmaceuticals, biologics, and consumer health products.Catalent developed OptiGel®Lock as an abuse-deterrent technology for controlled substances, leveraging the inherent properties of softgel technology to achieve abuse prevention while delivering the intended benefits to patients. With the rise of large molecule therapies, particularly proteins and peptides, Catalent’s team innovated OptiGel®BIO as a means to orally deliver these molecules, once again utilizing softgel technology to stabilize and enhance the absorption of large molecules, with the potential to significantly improve patient compliance.
Catalent, Inc.
NewJersey,United States of America
more than 500 people
April 01, 2007
solutions@catalent.com

Enterprise Profile

Industrial Sector
Health Supplement Manufacturing New Drug Development Manufacture of Biological Pharmaceutical Products CDMO
Technology
Biotechnology
Concept
Therapeutic Products
Application Scenarios
Innovative Drugs